In conclusion, we demonstrated that the control of thyroid differentiation‐related transcription factors via the METTL3‐SETMAR‐SMARCA2 axis contributes to the differentiation of thyroid cancer. This evidence concerns the gene SMARCA2 and thyroid gland carcinoma.